awmsg logo



bismuth/metronidazole/tetracycline (Pylera®)


Reference No. 1544

Publication date:
01/05/2012


Appraisal information

bismuth/metronidazole/tetracycline (Pylera®) 140 mg/125 mg/125 mg capsule


Company: Aptalis Pharma
BNF category: Gastro-intestinal system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 25/04/2012

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, bismuth/metronidazole/tetracycline (Pylera®) cannot be endorsed for use within NHS Wales in combination with omeprazole for the eradication of Helicobacter pylori and prevention of relapse of peptic ulcers in patients with active, or a history of, H. pylori associated ulcers.
Statement of Advice (SOA)
Download